Currently, the HIV treatment regimen for people in the early stages is a tenofovir and lamivudine tablet, combined with dolutegravir, which is a newer antiretroviral drug.
The SUS distributes free of charge the treatment of AIDS and the registration of patients in the SUS is mandatory for the delivery of antiretroviral drugs, as well as the presentation of a prescription.
- The recommended dose is 1 tablet per day.
- Orally.
- With or without food.
- Treatment should not be discontinued without the doctor’s knowledge.
Irregular use of antiretrovirals, as well as discontinuation of treatment, can lead to resistance of the virus to these medicines, which can make treatment ineffective.To facilitate adherence to therapy, the person should adjust the hours of medication intake to their daily routine..
This medicine is counterinditive in people with hypersensitivity to one of the components of the formula.In addition, this medicine should not be used by pregnant women, breastfeeding women or children under 18 years of age, except by medical recommendation.
The most common side effects that can occur during treatment with tenofovir and lamivudine are dizziness, gastrointestinal disorders, red spots and itchy plaques in the body, headache, muscle pain, diarrhea, depression, weakness and nausea.
In addition, although rarer, vomiting, dizziness and excess intestinal gas can also occur.